Today: 20 May 2026
LSEG share price drops 4% in early London trade as AI fears linger and buyback rolls on
6 February 2026
1 min read

LSEG share price drops 4% in early London trade as AI fears linger and buyback rolls on

London, Feb 6, 2026, 08:01 GMT — Regular session

  • Shares of London Stock Exchange Group fell about 4% in early trading, erasing gains following a 5.8% rise on Thursday
  • LSEG announced fresh buyback transactions and intends to cancel the repurchased shares
  • With full-year results due on Feb. 26, investors are watching for any shifts in wording around AI risk

Shares of London Stock Exchange Group (LSEG.L) fell about 4% shortly after Friday’s open, erasing part of the previous day’s gains. Concerns over AI disruption continue to weigh on investors. At 0802 GMT, the stock traded at 7,282 pence, down from Wednesday’s close of 7,586, fluctuating between roughly 7,183 and 7,304 pence.

The stock has become a proxy for the wider turmoil engulfing “data and workflow” firms after Anthropic’s new AI tools sparked fresh questions about subscription model durability. Generative AI is now capable of automating tasks such as research, analysis, and document processing, squeezing these companies. “An awakening to the disruptive power of AI,” said James St. Aubin, chief investment officer at Ocean Park Asset Management. Reuters

Investors are jittery as LSEG gears up to report full-year results for 2025 on Feb. 26. Attention is zeroed in on growth within its data and analytics units, alongside how the company plans to invest in AI while keeping margins intact. The group also confirmed it will continue its buyback program right up to the earnings announcement.

On Thursday, LSEG surged 5.8% as London-listed tech and analytics stocks recovered from earlier drops, despite the FTSE 100 closing down. Trading volume in LSEG climbed to about 2.3 million shares, significantly higher than the 50-day average of roughly 1.5 million, according to market data.

Ahead of Friday’s open, LSEG revealed it bought back 256,419 shares on Feb. 5 at an average price of 7,533.05 pence per share under its ongoing buyback plan. These shares will be cancelled. The company also updated its total voting rights after the repurchase.

Some investors are on the lookout for a bottom in AI-related software and data stocks, though caution is widespread. Art Hogan, chief market strategist at B Riley Wealth, called the selloff “Software-mageddon.” Walter Todd, CIO at Greenwood Capital, weighed in, saying, “I don’t think this wholesale replacement of the existing software infrastructure for the AI solution in these situations is realistic.” Reuters

The risk is obvious: if clients begin turning to AI tools instead of parts of premium data and workflow products, pricing power might weaken. That would challenge the case for a valuation built on loyal subscriptions. On top of that, a downturn in global markets could quickly reduce trading and capital markets activity, hitting the results almost right away.

Traders remain focused on whether the tech-driven selloff fueling this week’s swings will continue, along with fresh broker analyses on “AI winners versus losers” in European data stocks. For LSEG, all attention shifts to Feb. 26, when it reports full-year earnings. Investors are set to zero in on demand patterns, customer retention, and how AI investments are paying off.

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
P&G stock price climbs in late trade as investors rotate to defensives — and an insider sale hits the tape
Previous Story

P&G stock price climbs in late trade as investors rotate to defensives — and an insider sale hits the tape

Compass Group share price slips again as AI fears linger after Q1 update
Next Story

Compass Group share price slips again as AI fears linger after Q1 update

Go toTop